RE: Global NIPT vendors including (YGEN)21 Feb 2023 16:30
According to the ceo, many are leaving the Nipt scene, which leaves Ygen in a much stronger position. They don't see many of the old names tendering any more.
Wonder if that is all they have to announce, as it's not news if the website and Ambry is what it's all about. The oncology stuff could well be a great addition to the company.
I don't think it's allowed to pre announce a material rns, so it will be nothing to excite the market or investors too much imo. Hopefully I am wrong, we'll soon find out.